You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 5, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Despoina Sidira1, Angeliki Siafaka2, Dimosthenis Chrysikos3
1Medical School, National and Kapodistrian University of Athens, Athens, Greece. despinasidirag@gmail.com.
Selenium compounds show promise as an adjuvant therapy for triple-negative breast cancer (TNBC). This research indicates selenium enhances chemotherapy effectiveness and reduces cancer cell growth and metastasis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: